Exogenous VEGF-C Augments the Efficacy of Therapeutic Lymphangiogenesis Induced by Allogenic Bone Marrow Stromal Cells in a Rabbit Model of Limb Secondary Lymphedema

Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases

(2010) Xiao-Lei Wang et al.   BMC CANCER

Multipotent Mesenchymal Stem Cells Acquire a Lymphendothelial Phenotype and Enhance Lymphatic Regeneration In Vivo

(2009) Claudius Conrad et al.   CIRCULATION

Therapeutic Responses to Exogenous VEGF-C Administration in Experimental Lymphedema: Immunohistochemical and Molecular Characterization

(2009) Da Pan Jin et al.   Lymphatic Research and Biology

Autologous Bone Marrow Stromal Cells Transplantation for the Treatment of Secondary Arm Lymphedema: A Prospective Controlled Study in Patients with Breast Cancer Related Lymphedema

(2008) C. Hou et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

VEGF-C, a Lymphatic Growth Factor, Is a RANKL Target Gene in Osteoclasts That Enhances Osteoclastic Bone Resorption through an Autocrine Mechanism

(2008) Qian Zhang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Effect of vascular endothelial growth factor C (VEGF-C) gene transfer in rat model of secondary lymphedema

(2008) Yanli Liu et al.   VASCULAR PHARMACOLOGY